Objectives
- To understand and leverage Benefit-Risk methodologies for efficient and effective decision-making
- To collaborate across industry, academia, and public bodies and across geographies to provide recommendations on key methodological issues across product life cycles
- To increase use and acceptance of Benefit-Risk methodologies with case study examples
- To disseminate external information to the broader community with conferences, workshops, seminars, and publications
Who are we
The Benefit-Risk ESIG was formed in 2012 with the vision to ensure industry professionals understood and effectively utilize Benefit-Risk methods throughout the entire medicinal product lifecycle process. The group is open to professionals from industry, academia, and public bodies (including regulatory and HTA agencies).
How to get in touch
We welcome new members and collaborators! Please reach out to Shahrul Mt-Isa or Marco Boeri if you have an interest in being involved in this ESIG, or have an interesting case study or experience of carrying out a structured Benefit-Risk assessment to share.
Latest news
2024 Focus
Upcoming events